Marco Barazas

2.3k total citations
7 papers, 361 citations indexed

About

Marco Barazas is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Marco Barazas has authored 7 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 1 paper in Genetics. Recurrent topics in Marco Barazas's work include CRISPR and Genetic Engineering (4 papers), DNA Repair Mechanisms (3 papers) and PARP inhibition in cancer therapy (3 papers). Marco Barazas is often cited by papers focused on CRISPR and Genetic Engineering (4 papers), DNA Repair Mechanisms (3 papers) and PARP inhibition in cancer therapy (3 papers). Marco Barazas collaborates with scholars based in Netherlands, Switzerland and United Kingdom. Marco Barazas's co-authors include Jos Jonkers, Sven Rottenberg, Stefano Annunziato, Marieke van de Ven, Ewa Gogola, J. Ross Chapman, Hans Clevers, Julian R. de Ruiter, Piet Borst and Sohvi Blatter and has published in prestigious journals such as Nature Communications, Nature Methods and Cancer Research.

In The Last Decade

Marco Barazas

7 papers receiving 359 citations

Peers

Countries citing papers authored by Marco Barazas

Since Specialization

Citations

This map shows the geographic impact of Marco Barazas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Barazas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Barazas more than expected).

Fields of papers citing papers by Marco Barazas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Barazas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Barazas. The network helps show where Marco Barazas may publish in the future.

Co-authorship network of co-authors of Marco Barazas

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Barazas. A scholar is included among the top collaborators of Marco Barazas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Barazas. Marco Barazas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient Tumors 2018 ·Cancer Research ·Marco Barazas, Alessia Gasparini, Yike Huang, Aslι Küçükosmanoğlu, Stefano Annunziato, Peter Bouwman, Wendy Sol, Ariena Kersbergen, Natalie Proost, Renske de Korte‐Grimmerink, Marieke van de Ven, Jos Jonkers, Gerben R. Borst, Sven Rottenberg	36
2	The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells 2018 ·Cell Reports ·Marco Barazas, Stefano Annunziato, Stephen J. Pettitt, Inge de Krijger, (unknown), Stefan J. Roobol, Catrin Lutz, Jessica Frankum, Fei Song, Rachel Brough, Bastiaan Evers, Ewa Gogola, Jinhyuk Bhin, Marieke van de Ven, Dik C. van Gent, Jacqueline J.L. Jacobs, J. Ross Chapman, Christopher J. Lord, Jos Jonkers, Sven Rottenberg	102
3	The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivity 2018 ·Nature Communications ·Jordan R. Becker, Raquel Cuella-Martin, Marco Barazas, Rui Liu, Catarina Oliveira, Antony W. Oliver, (unknown), Abbey B. Holt, Andrew N. Blackford, Jörg Heierhorst, Jos Jonkers, Sven Rottenberg, J. Ross Chapman	83
4	BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance 2017 ·Nature Methods ·Alexandra A. Duarte, Ewa Gogola, Norman Sachs, Marco Barazas, Stefano Annunziato, Julian R. de Ruiter, Arno Velds, Sohvi Blatter, Julia M. Houthuijzen, Marieke van de Ven, Hans Clevers, Piet Borst, Jos Jonkers, Sven Rottenberg	98
5	Studying cancer drug resistance using BRCA-deficient mouse mammary tumor organoids 2017 ·Protocol Exchange ·Alexandra A. Duarte, Ewa Gogola, Norman Sachs, Marco Barazas, Stefano Annunziato, Julian R. de Ruiter, Arno Velds, Sohvi Blatter, Julia M. Houthuijzen, Marieke van de Ven, Hans Clevers, Piet Borst, Jos Jonkers, Sven Rottenberg	1
6	Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype 2017 ·Neuro-Oncology ·Jian Teng, (unknown), Lotte Hiddingh, Litia Carvalho, Mark C. de Gooijer, Hiroaki Wakimoto, Marco Barazas, Marie Tannous, S. Andrew, David P. Noske, Pieter Wesseling, Thomas Würdinger, Tracy T. Batchelor, Bakhos A. Tannous	32
7	Genetic Dissection of Cancer Development, Therapy Response, and Resistance in Mouse Models of Breast Cancer 2016 ·Cold Spring Harbor Symposia on Quantitative Biology ·Stefano Annunziato, Marco Barazas, Sven Rottenberg, Jos Jonkers	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact